logo-loader
viewAlliance Minerals Assets Ltd

Alliance Mineral Assets welcomes Galaxy Resources as a substantial shareholder

The shareholding is the result of Galaxy participating in a recent $32.5 million capital raising.

shareholder concept
Only two strategic major companies participated in the raising – Galaxy and Jiangxi

Alliance Mineral Assets Ltd (ASX:A40) has had lithium miner Galaxy Resources Ltd (ASX:GXY) become a 12.22% substantial shareholder in the company.

Galaxy recently invested $22.5 million in the company through a $32.5 million placement to become its largest shareholder.

The other $10 million was invested by a generator and motor producing German-based subsidiary of Jiangxi Special Electric Motor Co., Ltd.

The capital raised in the placement will go towards funding process plant upgrades as well as continued exploration across the producing Bald Hill lithium mine’s prospective areas.

READ: Alliance Mineral Assets maintains speculative buy recommendation from Hartleys

Alliance recently achieved quarterly records for lithium production and shipping totals from the Bald Hill Lithium and Tantalum Mine in Western Australia.

It produced 38,291 tonnes of spodumene concentrate grading 6.1% lithium oxide in the March quarter prompting resources-focused broker Hartleys to re-iterate its Spec Buy recommendation.

Quick facts: Alliance Minerals Assets Ltd

Price: - AUD

ASX:A40
Market: ASX
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Algernon Pharmaceuticals receives US FDA clearance for Phase 2b/3 human study

Algernon Pharmaceuticals Inc. (CSE: AGN-OTCQB: AGNPF) CEO Christopher Moreau joined Steve Darling from Proactive Vancouver with major news for the company that they have received clearance from the U.S. FDA for its multinational Phase 2b/3 study of Ifenprodil as a potential treatment for...

3 hours, 44 minutes ago

2 min read